Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
3.000
-0.130 (-4.15%)
At close: Nov 16, 2026, 4:00 PM EST
2.960
-0.040 (-1.33%)
After-hours: Nov 16, 2026, 7:30 PM EST
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $70.37 million as of November 16, 2026. It is the 27,335th most valuable company in the world and the 4,311th biggest in the United States. Its market cap has decreased by 42.70% in one year.
Market Cap
70.37M
Enterprise Value
34.57M
1-Year Change
-42.70%
Global Rank
Country Rank
#4,311 United States
Category
ChartMarket Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $70.37M, an increase of 494.51%. That is a compound annual growth rate of 58.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 70.37M | -42.01% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 79.59M |
| Atara Biotherapeutics | 77.29M |
| Nutriband | 74.15M |
| Rani Therapeutics Holdings | 73.36M |
| Milestone Pharmaceuticals | 73.27M |
| Tiziana Life Sciences | 72.96M |
| OKYO Pharma | 70.85M |
| Corbus Pharmaceuticals Holdings | 69.86M |